|
US5284956A
(en)
|
1988-09-06 |
1994-02-08 |
Hoffmann-La Roche Inc. |
Liquid crystalline mixtures containing 2-(2-fluorophenyl) pyridines
|
|
JP2881750B2
(ja)
|
1988-09-06 |
1999-04-12 |
エフ・ホフマン‐ラ ロシユ アーゲー |
２‐（２‐フルオロフエニル）‐ピリジン
|
|
AU742425B2
(en)
|
1998-06-11 |
2002-01-03 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
WO2000074679A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
|
US6890940B2
(en)
|
2001-06-29 |
2005-05-10 |
Kowa Co., Ltd. |
Bis(2-aryl-5-pyridyl) derivatives
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US20030158209A1
(en)
|
2001-10-09 |
2003-08-21 |
Neurocrine Biosciences Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US6664273B2
(en)
|
2001-11-26 |
2003-12-16 |
Schering Corporation |
Piperidine based MCH antagonists for treatment of obesity and CNS disorders
|
|
WO2003068738A1
(en)
|
2002-02-11 |
2003-08-21 |
Neurocrine Biosciences, Inc. |
Pyrrole derivatives as ligands of melanocortin receptors
|
|
JP2005534632A
(ja)
|
2002-05-10 |
2005-11-17 |
ニューロクライン バイオサイエンセズ， インコーポレイテッド |
メラノコルチンレセプターリガンドとしての置換ピペラジン
|
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
EP1460073A1
(en)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
NZ544820A
(en)
|
2003-08-11 |
2009-02-28 |
Hoffmann La Roche |
Piperazine with or-substituted phenyl group and their use as GlyT1 inhibitors
|
|
EP1663232B1
(en)
|
2003-09-09 |
2007-10-03 |
F. Hoffmann-La Roche Ag |
1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
|
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
|
US20050119252A1
(en)
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
EP1871762A2
(en)
|
2005-04-18 |
2008-01-02 |
Neurogen Corporation |
Subtituted heteroaryl cb1 antagonists
|
|
CA2625877A1
(en)
|
2005-10-18 |
2007-04-26 |
Merck & Co., Inc. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
RU2303597C1
(ru)
|
2006-05-12 |
2007-07-27 |
Иващенко Андрей Александрович |
Фармацевтическая композиция, способы ее получения и применения
|
|
AU2009284098B2
(en)
|
2008-08-22 |
2012-03-29 |
Astex Therapeutics Ltd. |
Pyrrolopyrimidine compounds as CDK inhibitors
|
|
KR20110050680A
(ko)
|
2008-09-02 |
2011-05-16 |
뉴로서치 에이/에스 |
트리아졸 유도체, 및 니코틴성 아세틸콜린 수용체 조절제로서의 이들의 용도
|
|
PT2344474E
(pt)
|
2008-09-02 |
2015-12-28 |
Novartis Ag |
Derivados de picolinamida como inibidores de cinase
|
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
PE20120693A1
(es)
|
2009-06-29 |
2012-07-04 |
Agios Pharmaceuticals Inc |
Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
|
|
EP2715754B1
(en)
|
2011-05-31 |
2015-07-29 |
Linak A/S |
Actuator
|
|
FR3017867A1
(fr)
|
2014-02-21 |
2015-08-28 |
Inventiva |
Nouveaux composes de type phenylazetidine carboxylate ou carboxamide
|
|
EP3199156A1
(de)
|
2016-02-01 |
2017-08-02 |
Heinrich-Heine-Universität Düsseldorf |
Verwendung von glycin-transporter-1-antagonisten als zentralnervöse analgetika
|
|
EP3480198B1
(en)
|
2016-06-30 |
2021-05-05 |
Riken |
Novel compound or pharmaceutically acceptable salt thereof
|
|
US11377436B2
(en)
|
2017-07-12 |
2022-07-05 |
The Brigham And Women's Hospital, Inc. |
EAAT2 enhancing molecules
|
|
SG11202003407VA
(en)
|
2017-10-17 |
2020-05-28 |
Merck Patent Gmbh |
PYRIMIDINE TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
|
|
KR102695210B1
(ko)
|
2018-06-05 |
2024-08-13 |
크리네틱스 파마슈티칼스, 인크. |
멜라노코르틴 아형-2 수용체(mc2r) 길항제 및 이의 용도
|
|
WO2021091788A1
(en)
|
2019-11-07 |
2021-05-14 |
Crinetics Pharmaceuticals, Inc. |
Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
|
|
JP7672406B2
(ja)
|
2019-12-18 |
2025-05-07 |
クリネティックス ファーマシューティカルズ，インク． |
Ｇｅｍ－二置換ピペリジンメラノコルチンサブタイプ－２受容体（ｍｃ２ｒ）アンタゴニストおよびその使用
|
|
JP7651574B2
(ja)
|
2019-12-23 |
2025-03-26 |
クリネティックス ファーマシューティカルズ，インク． |
スピロ環式ピペリジンメラノコルチンサブタイプ－２受容体（ｍｃ２ｒ）アンタゴニストおよびその使用
|
|
US11565011B2
(en)
|
2020-09-18 |
2023-01-31 |
Ncr Corporation |
Sterilizing media cassette
|
|
WO2023219952A1
(en)
|
2022-05-10 |
2023-11-16 |
Radionetics Oncology, Inc. |
Melanocortin type 2 receptor (mc2r) targeted therapeutics and uses thereof
|